• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
  • Street Notes
  • Authors
    • Bruce Kamich
    • Doug Kass
    • Jim Cramer
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Daily Swing Trade Archive
    • Income Seeker
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • Trifecta Stocks
  1. Home
  2. / Investing
  3. / Healthcare

Market Bifurcation: Individual Stocks Are Acting Better Than the Indices

This underperformance is being caused by pockets of weakness in bigger-cap names.
By JAMES "REV SHARK" DEPORRE
May 17, 2018 | 08:17 AM EDT
Stocks quotes in this article: IWM, GOOGL, CAT, GS, MMM, VZ, AAPL, ARNA, SRPT, RCKT

The big story of this market in recent weeks isn't the bounce in the major indices but how well small-caps have been performing. The Russell 2000 ETF (IWM) has bounced 4.62% over the last nine days compared to the Dow Jones Industrial Average, which is up 3.5% during the same period. But what is most interesting, is that the IWM has gained 2.5% over the last month while the S&P 500 has increased only 0.6%.

Individual stocks have been outperforming for weeks and that has driven the IWM to new all-time highs while the DJIA and the S&P 500 are not even close to their March highs, let alone the all-time highs in January.

Obviously, this underperformance is caused by pockets of weakness in bigger-cap names. Apple (AAPL) has been performing well but other big names such as Alphabet (GOOGL) , Caterpillar (CAT) , Goldman Sachs (GS) , 3M (MMM) , Verizon (VZ) and many more have been lagging.

In small-caps, the speculative biotechnology names and some of the mighty midgets are keep aggressive traders busy. I've been highlighting many of the movers in biotechnology lately such as my Stock of the Week, Arena Pharmaceuticals (ARNA) , and other favorites like Sarepta Therapetics (SRPT) and Rocket Pharmaceuticals (RCKT) .

This bifurcated market action makes it tough on timers. If you look at the S&P 500 or DJIA there are some solid technical reasons for being concerned, but if you look at the small-cap indices those arguments go out the window. The Nasdaq and Nasdaq 100 are somewhere in between the two and have the potential to make a run at their 2018 highs.

My game plan for dealing with this is to focus on trading the strength in the small-caps and not to worry much about the timing of the senior indices. The bearish spin on this small-cap outperformance is that it is late-stage action. The speculation is what occurs near the top, similar to what we saw back in 2000 when the Nasdaq and internet stocks had a final frenzy before a major top occurred.

Perhaps, but the bullish argument is that it is impossible to time a turn here. We simply have to ride the wave as long as we can and watch for a shift in the price action. It is becoming much harder to find good entry points after this run but the price action is healthy.

Ironically, the underperformance by the indices probably helps to create a "wall of worry" effect. While the S&P 500 offers reasons to worry, many stocks are still running so there is a tendency to keep putting capital to work to avoid missing out. Higher interest rates also contribute to this wall of worry effect.

We have another very mild start Thursday morning. I'll be managing positions closely and protecting gains. The hunt for new ideas is becoming more difficult but there isn't any reason to be aggressively negative.

Apple, Alphabet, Goldman Sachs and 3M are holdings in Jim Cramer's Action Alerts PLUS Charitable Trust Portfolio. Want to be alerted before Cramer buys or sells these stocks? Learn more now.

Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

At the time of publication, Rev Shark was long ARNA, SRPT and RCKT.

Action Alerts PLUS, which Cramer manages as a charitable trust, is long AAPL, GOOGL, GS and MMM.

TAGS: Investing | U.S. Equity | Healthcare | Futures | Markets | Stocks

More from Healthcare

Two Dividend Stocks I Own and One I'm Looking to Buy

Dave Butler
Feb 13, 2019 3:23 PM EST

These stocks aren't going out of style.

Ventas Is Showing Some Softness Now, Raise Sell Stop Protection

Bruce Kamich
Feb 13, 2019 9:26 AM EST

The company is relying on several building blocks to return to growth.

Evolus Stockholders May Be Frowning in the Short Run

Bruce Kamich
Feb 8, 2019 10:41 AM EST

Shares of the Botox competitor could correct/consolidate after a recent surge.

Centene Splits 2 For 1 Which Changes the Chart Levels but Not the Trends

Bruce Kamich
Feb 7, 2019 9:45 AM EST

With the stock split a fresh look at the split adjusted stock is now in order.

Alphabet's Healthcare Initiative Squares Off With Amazon, Apple

Kevin Curran
Feb 4, 2019 4:03 PM EST

Healthcare is attracting some very healthy competition among mega-cap names.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 04:01 PM EST KEVIN CURRAN

    Pepsi Kicks off 2019 on a Positive Note

    Pepsi's earnings may not have been immaculate, but...
  • 10:08 AM EST BOB LANG

    Rolling up the Arista

    on Tuesday this week I posted a trade idea here an...
  • 08:11 AM EST KEVIN CURRAN

    Pepsi Earnings Call Notes

    As my first article is in edit, here are some sele...
  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2019 TheStreet, Inc., 14 Wall Street, 15th Fl, NY, NY 10005

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login